Council Members in this Study Group: 797
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Harold Bays, MDPresident and Medical Director
L-MARC Research Center ![]()
Harold Bays, MD, FACP, FACE, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...
Director of Interventional Cardiology
NORTH OHIO HEART CENTER, INC ![]()
Charles O'Shaughnessy, MD, is the Director of Interventional Cardiology at North Ohio Heart Center, Ohio. Dr. O'Shaughnessy's clinical interests are in interventional cardiology including balloon angioplasty, laser directional atherectomy, stent placement, and rotoblator. He is very active in clinical...
Professor of Medicine
Finch University of Health Science-Chicago Medical School ![]()
Rohit Arora, MD, FACC, FAHA, FASCI, FACP, is Professor of Medicine and Professor of Physiology and Biophysics at Chicago Medical School. He is also the Chairman of Cardiology and Associate Chairman of Medicine in the Department of Medicine. Previously, he was Chief of Cardiology at UMDNJ and Director...
Director of Cardiovascular Research
Sinai Hospital of Baltimore, Inc. ![]()
Paul Gurbel, MD, is Director of Cardiovascular Research at the Center for Thrombosis Research at Sinai Hospital of Baltimore. Dr. Gurbel has authored over 100 peer-reviewed papers related primarily to coronary thrombosis and interventional cardiology. His particular expertise is in translational platelet...
Cardiologist
NEW YORK UNIVERSITY (INC) ![]()
Daniel Fisher, MD, FACC, FACP, is a Cardiologist at NYU Medical Center. He has a private practice in Cardiology and specializes in non-invasive cardiology. Dr. Fisher is board certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology. He has lectured frequently on such topicsas...
Hossein Ardehali, MD, PhDAssistant Professor
Northwestern University, Feinberg School of Medicine ![]()
Hossein Ardehali, MD, PhD, is an Assistant Professor of Medicine at Feinberg Cardiovascular Institute in Illinois. His specialties include lipid metabolism, preventive cardiology, electrophysiology and heart failure. Dr. Ardehali's basic science research interest is in the areas of reperfusion injury...
Clinical Director
NEW YORK UNIVERSITY (INC) ![]()
Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub has written textbook chapters on evaluation...
Marina Raikhel, MDDirector
TORRANCE MEMORIAL MEDICAL CENTER ![]()
Marina Raikhel, MD, is an active family practitioner with a particular interest in primary care and ob/gyn focus. She has expertise in the treatment of a wide variety of internal medicine conditions, with special focus on diabetes, hypertension, obesity, anxiety, and depression. She is Director ofTorrance...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Ghana Targets Health Tourism Boom: More Evidence of Globalization
October 31, 2009
Ghana targets health tourism boom | news.bbc.co.uk
Just as high tech products are manufactured in Asian countries for a fraction of the cost, medical procedures will be provided in less developed countries for a fraction of the cost in the not so distant future.It will initially be low tech procedures such as cosmetic operations and minor procedures...
Percutaneous valve repair – next battle among cardiovascular device companies?
October 4, 2009
Abbott To Acquire Evalve, Inc., A Leader In Minimally Invasive Cardiac Valve Repair Technology | www.medicalnewstoday.com
By acquiring promising technology in the percutaneous valve arena, as well as enjoying an already established reputation among interventional cardiologists, Abbott will position itself as a major player in an emerging technology market, and become a comprehensive provider for interventional cardiology...
A new treatment for a major problem.
September 30, 2009
ACC: Device May Prevent Stroke in AF Patients | www.medpagetoday.com
Atrial fibrillation is a very common condition that significantly increase the risk of stroke, especially in the older population. Vitamin K antagonists are the only current effective treatment in the higher risk population to reduce stroke. Any new treatment has a huge potential to help reduce risk,...
September 30, 2009
Ronald Innerfield, MD, Vice President of Clinical Affairs, Evidence Based Medicine, Inc.
Controls to blood sugar 'cuts stroke risk' | www.barchester.com
There have been many epidemiologic studies showing a very tight correlation between baseline A1c and cardiovascular mortalityDespite this, five major randomized prospective studies have failed to show any macrovascular benefit for tighter glucose controlThe logical conclusion is that glucose is, therefore,...
How much market will MADIT-CRT drive?
September 30, 2009
Cardiac-Resynchronization Therapy for the Prevention of Heart Failure Events | content.nejm.org
While this trial had a positive endpoint, it was not a mortality endpoint. A major defect is a lack of a medical therapy alone arm. That said, prevention of heart failure episodes is a laudable goal and given the expense to the US system of CHF, this could be a worthwhile treatment, however thenumber...
| Study Group Name | No. Members |
|---|---|
| Heart Failure Specialists (US) | 978 |
| General Cardiologists (US) | 1333 |
| Non-Electrophysiologist Cardiologists (US) | 860 |
| Physicians who Treat Arrhythmia (US) | 306 |
| Physicians who Treat Hypercholesterolemia in the U.S. | 251 |
| Interventional Cardiologists (US) | 438 |
| Niaspan Prescribers for Raising HDL | 144 |
Leading Experts in Physicians who Treat Hypertension (US) Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
Leading Experts in Physicians who Treat Hypertension (US) have not participated in any GLG webcasts.